purine has been researched along with Leukemia, Myelogenous, Chronic, BCR-ABL Positive in 2 studies
1H-purine : The 1H-tautomer of purine.
3H-purine : The 3H-tautomer of purine.
9H-purine : The 9H-tautomer of purine.
7H-purine : The 7H-tautomer of purine.
Leukemia, Myelogenous, Chronic, BCR-ABL Positive: Clonal hematopoetic disorder caused by an acquired genetic defect in PLURIPOTENT STEM CELLS. It starts in MYELOID CELLS of the bone marrow, invades the blood and then other organs. The condition progresses from a stable, more indolent, chronic phase (LEUKEMIA, MYELOID, CHRONIC PHASE) lasting up to 7 years, to an advanced phase composed of an accelerated phase (LEUKEMIA, MYELOID, ACCELERATED PHASE) and BLAST CRISIS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mesárosová, A | 1 |
| Hrivnáková, A | 1 |
| Klobusická, M | 1 |
| Babusíková, O | 1 |
| Koizumi, S | 1 |
2 other studies available for purine and Leukemia, Myelogenous, Chronic, BCR-ABL Positive
| Article | Year |
|---|---|
Chronic myeloid leukemia: correlation between purine metabolism enzyme activities and membrane immunophenotype.
Topics: Adenosine Deaminase; Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antigens, C | 1995 |
Impairment of methotrexate (MTX)-polyglutamate formation of MTX-resistant K562 cell lines.
Topics: Drug Resistance; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Methotrexate; Peptide Bio | 1988 |